Echocardiographyc and histomorphometric assessment of the effects of pharmacological antagonism of endothelin receptors in the Sugen 5416/hypoxia rat model of pulmonary hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018
The influence of epithelium on the effect of isoprenaline incubation in responsiveness of guinea-pig trachea to b-adrenergic agonist and antagonist Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III Year: 2007
Dual endothelin-1 receptor antagonism prevents chronic intermittent hypoxia-induced cardiovascular alterations in rats Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing Year: 2008
NTP42, an antagonist of the thromboxane receptor, attenuates experimentally-induced pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019
Pulmonary vasoconstriction evoked by d-norfenfluramine but not d-fenfluramine is modified by pre-treatment with an SSRI in the Wistar rat lung Source: Eur Respir J 2002; 20: Suppl. 38, 24s Year: 2002
Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats Source: Eur Respir J 2010; 35: 904-912 Year: 2010
Esterification of iloprost enhances its protective effects on pulmonary endothelium Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020
Optimization of tissue targeting properties of macitentan, a new dual endothelin receptor antagonist, improves its efficacy in a rat model of pulmonary fibrosis associated with pulmonary arterial hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011
Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 24s Year: 2002
The non-prostanoid IP receptor agonist, APD811 (ralinepag) has potent antiproliferative and vasorelaxant properties in human pulmonary artery Source: International Congress 2017 – Experimental PH Year: 2017
Effects of iptkalim hydrochloride on endothelin-1-induced pulmonary hypertension in rats Source: Eur Respir J 2005; 26: Suppl. 49, 291s Year: 2005
VIP prevents and reverses monocrotaline-induced PAH: Further protection by combination with bosentan Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010
Involvement of angiotensins on bronchomotor effects of adenosine Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009
Effects of Sildenafil on hypoxic pulmonary vasoconstriction in dogs Source: Eur Respir J 2001; 18: Suppl. 33, 490s Year: 2001
Effect of zamicastat, a dopamine beta-hydroxylase inhibitor, on the monocrotaline rat model of pulmonary arterial hypertension Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020
Dual endothelin receptor antagonism: setting standards in PAH Source: Eur Respir Rev 2008; 17: 13-18 Year: 2007
Endothelin-a receptor antagonists reduce eNOS gene expression in rats with chronic hypoxic pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 271s Year: 2003
Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007
Protection of vasoconstriction and lung function impairment by endothelin-receptor blockers and vasoactive intestinal peptide (VIP) in isolated perfused rat lungs Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007
Bosentan inhibits cigarette smoke-induced endothelin receptor expression in pulmonary arteries Source: Eur Respir J 2012; 39: 927-938 Year: 2012